Bioengineered Stromal Cell-Derived Factor-1α Analogue Delivered as an Angiogenic Therapy Significantly Restores Viscoelastic Material Properties of Infarcted Cardiac Muscle

Ischemic heart disease is a major health problem worldwide, and current therapies fail to address microrevascularization. Previously, our group demonstrated that the sustained release of novel engineered stromal cell-derived factor 1-α analogue (ESA) limits infarct spreading, collagen deposition, im...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Biomech Eng
Main Authors: Trubelja, Alen, MacArthur, John W., Sarver, Joseph J., Cohen, Jeffrey E., Hung, George, Shudo, Yasuhiro, Fairman, Alexander S., Patel, Jay, Edwards, Bryan B., Damrauer, Scott M., Hiesinger, William, Atluri, Pavan, Joseph Woo, Y.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Mechanical Engineers 2014
Assuntos:
Technical Brief
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4307777/
https://ncbi.nlm.nih.gov/pubmed/24860865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1115/1.4027731
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados